Sun Pharma to launch Bempedoic Acid under brand name Brillo?

18 May 2022 , 04:03 PM

Sun Pharmaceutical Industries announced that one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India for reducing low-density lipoprotein(LDL) cholesterol. The company will launch the drug under the brand name ?Brillo??. Brillo? is a first-in-class drug which has a new mechanism of action compared to the currently available lipid-lowering agents. It is indicated for people who have an inherited genetic disorder that causes high cholesterol levels or established heart disease where cholesterol levels remain high, despite lifestyle changes and the use of maximum tolerated dose of statins.Powered by Capital Market – Live News